Valtruis

Valtruis is a venture capital firm founded in 2021 and based in New York, New York. The company specializes in investing in and collaborating with innovative leaders within the healthcare sector. Valtruis aims to support disruptive ventures that align with its mission of transforming the healthcare landscape through strategic partnerships and investment.

Anna Haghgooie

Managing Director

Karey Witty

Managing Director

Past deals in Hospital

HarmonyCares

Venture Round in 2024
HarmonyCares specializes in delivering high-quality primary healthcare at home. They offer an integrated model that includes ancillary services such as home health, hospice, palliative care, radiology, and laboratory testing.

Tuesday Health

Venture Round in 2024
Tuesday Health is a healthcare company that focuses on providing supportive care to individuals with serious illnesses. It aims to ease symptoms and reduce stress, enabling patients to spend more time at home with their loved ones. The company specializes in personalized, innovative care plans and delivers compassionate, supportive care through a value-based palliative care model.

Wellvana

Venture Round in 2023
Founded in 2018, Wellvana is a healthcare technology company based in Nashville, Tennessee. It develops a clinically integrated network platform that coordinates care across various settings, enabling real-time decision-making to optimize patient flow within the healthcare system. Wellvana offers direct primary care programs for employers and employees, and supports physicians by providing a framework for collaborative practice under payment models, ensuring financial stability.

HarmonyCares

Venture Round in 2021
HarmonyCares specializes in delivering high-quality primary healthcare at home. They offer an integrated model that includes ancillary services such as home health, hospice, palliative care, radiology, and laboratory testing.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.